Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Capital Expenditures (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Capital Expenditures for 16 consecutive years, with -$11.0 million as the latest value for Q1 2026.

  • Quarterly Capital Expenditures fell 34.0% to -$11.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Jan 2026, down 97.62% year-over-year, with the annual reading at $1000.0 for FY2026, 97.62% down from the prior year.
  • Capital Expenditures for Q1 2026 was -$11.0 million at Usana Health Sciences, down from $3.2 million in the prior quarter.
  • The five-year high for Capital Expenditures was $13.1 million in Q4 2023, with the low at -$13.2 million in Q1 2022.
  • Average Capital Expenditures over 5 years is $688823.5, with a median of $285000.0 recorded in 2022.
  • The sharpest move saw Capital Expenditures plummeted 162.77% in 2024, then soared 30096.15% in 2025.
  • Over 5 years, Capital Expenditures stood at $10.2 million in 2022, then increased by 28.58% to $13.1 million in 2023, then tumbled by 162.77% to -$8.2 million in 2024, then soared by 138.86% to $3.2 million in 2025, then tumbled by 444.81% to -$11.0 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$11.0 million, $3.2 million, and $7.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.